Dennis Calvert, CEO of BioLargo, Inc. (BLGO) was invited for another interview for Uptick Newswire Stock Day Podcast with host Everett Jolly. The main topic of the interview was BioLargo's recent creation of an engineering subsidiary called BioLargo Engineering, Science & Technologies, LLC. Dennis explained the financing the company secured to accelerate the new venture from Lincoln Park Capital. The new engineering company represents a huge expansion of BioLargo's technical capabilities, and will allow the company to take part in a myriad of commercial opportunities in the engineering services sector, as well as provide an effective mechanism for engineering and scaling-up BioLargo's AOS water treatment platform.
Dennis also gave listeners an update on CupriDyne Clean's growing commercial success, with its three national purchasing agreements with major national waste handling companies. Finally, he described BioLargo's huge opportunities in the advanced wound care market, with two Clyra Medical products soon applying for FDA 510(K) registration. These products will provide effective, safe, and gentle solutions for infection control, chronic wound therapy, and regenerative tissue therapy.
No comments:
Post a Comment